Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.
Heparin (HP) inhibits the proliferation of bovine pulmonary artery smooth muscle cells (BPASMC's), among other cell types in vitro. In order to develop a potential therapeutic agent to reverse vascular remodeling, we are involved in deciphering the relationship between the native HP structure and its antiproliferative potency. We have previously reported the influence of the molecular size and the effects of various O-sulfo and N-acetyl groups of HP on growth-inhibitory activity. In this study, to understand the influence of carboxyl groups in the HP structure required for endogenous activity, a chemically modified derivative of native HP was prepared by converting the carboxyl groups of hexuronic acid residues in HP to primary hydroxyl groups. This modification procedure involves the treatment of HP with N-(3-dimethylaminopropyl)-N-ethylcarbodiimide followed by reduction with NaBH(4) to yield carboxyl-reduced heparin (CR-HP). When compared to the antiproliferative potency of native HP on cultured BPASMC's at three dose levels (1, 10, and 100 microg/mL), the CR-HP showed significantly less potency at all the doses. These results suggest that hexuronic acid residues in both major and variable sequences in HP are essential for the antiproliferative properties of native HP.
Garg
Hari G
HG
Department of Medicine, Pulmonary/Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Hgarg@partners.org
Mrabat
Hicham
H
Yu
Lunyin
L
Freeman
Craig
C
Li
Boyangzi
B
Zhang
Fuming
F
Linhardt
Robert J
RJ
Hales
Charles A
CA
D000818:Animals; D001894:Borohydrides / Q000737:chemistry; D002417:Cattle; D049109:Cell Proliferation / Q000187:drug effects; D006493:Heparin / Q000737:chemistry* / Q000494:pharmacology*; D006603:Hexuronic Acids / Q000737:chemistry; D006878:Hydroxides / Q000737:chemistry; D032389:Myocytes, Smooth Muscle / Q000166:cytology* / Q000187:drug effects*; D010084:Oxidation-Reduction; D011651:Pulmonary Artery / Q000166:cytology*
D001894:Borohydrides; D006603:Hexuronic Acids; D006878:Hydroxides; C025364:sodium borohydride; D006493:Heparin; C031356:hydroxide ion
J Cell Biol. 1981 Aug;90(2):372-9
7287812
Biochim Biophys Acta. 2003 Nov 20;1639(3):225-31
14636954
Anal Biochem. 1988 Aug 1;172(2):410-9
3189786
Am Rev Respir Dis. 1983 Oct;128(4):747-51
6226226
Adv Carbohydr Chem Biochem. 2001;57:159-206
11836942
Carbohydr Res. 1995 Oct 16;276(1):183-97
8536254
Carbohydr Res. 2006 Nov 6;341(15):2607-12
16920092
J Pharm Sci. 1992 Aug;81(8):823-7
1328601
Carbohydr Res. 1990 Sep 5;204:131-9
2279243
Carbohydr Res. 2008 Sep 22;343(14):2406-10
18656855
Br J Exp Pathol. 1976 Oct;57(5):542-54
136978
Biochem Biophys Res Commun. 1997 Dec 8;241(1):18-23
9405227
Carbohydr Res. 2003 Jan 31;338(3):251-6
12543557
Biochem Biophys Res Commun. 1991 May 31;177(1):259-64
2043111
Exp Lung Res. 1981 Nov;2(4):257-71
7318779
J Biol Chem. 1967 May 25;242(10):2447-53
6026234
Clin Perinatol. 1984 Oct;11(3):525-49
6386268
Arch Biochem Biophys. 1999 Nov 15;371(2):228-33
10545209
Circ Res. 1980 Oct;47(4):578-83
6157501
Am J Physiol. 1996 Feb;270(2 Pt 1):L260-5
8779995
Nature. 1977 Feb 17;265(5595):625-6
859561
J Cell Physiol. 1985 Dec;125(3):499-506
3877732